Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Identifying novel SMYD3 interactors on the trail of cancer hallmarks. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3390/cancers12010142
10.3390/cancers12010142 · External reference
Overexpression of the SMYD3 promotes proliferation, migration, and invasion of pancreatic cancer
10.1007/s10620-019-05797-y · 2020 · External reference
10.1038/nature13320
10.1038/nature13320 · External reference
10.1016/j.ccell.2016.01.013
10.1016/j.ccell.2016.01.013 · External reference
SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma
10.1007/s13277-014-2891-z · 2015 · External reference
10.1093/nar/gky1221
10.1093/nar/gky1221 · External reference
SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
10.1016/j.humpath.2016.01.012 · 2016 · External reference
Overexpression of SMYD3 in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via Methylating H3K4 and H4K20
10.7150/jca.29861 · 2019 · External reference
A SMYD3 small-molecule inhibitor impairing cancer cell growth
10.1002/jcp.24975 · 2015 · External reference
Structure-based design of a novel SMYD3 inhibitor that bridges the SAM-and MEKK2-binding pockets
10.1016/j.str.2016.03.010 · 2016 · External reference
Novel oxindole sulfonamides and sulfamides: EPZ031686, the first orally bioavailable small molecule SMYD3 inhibitor
10.1021/acsmedchemlett.5b00272 · 2016 · External reference
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
10.1371/journal.pone.0197372 · 2018 · External reference
10.1038/ncb1151
10.1038/ncb1151 · External reference
10.1111/j.1349-7006.2006.00146.x
10.1111/j.1349-7006.2006.00146.x · External reference
10.1158/0008-5472.can-06-4126
10.1158/0008-5472.can-06-4126 · External reference
10.1016/j.canlet.2009.02.015
10.1016/j.canlet.2009.02.015 · External reference
10.4161/epi.19506
10.4161/epi.19506 · External reference
ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
10.1186/s13046-018-1011-0 · 2019 · External reference
10.1038/s41388-019-0766-x
10.1038/s41388-019-0766-x · External reference
10.5483/bmbrep.2008.41.4.294
10.5483/bmbrep.2008.41.4.294 · External reference
Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells
10.1007/s12032-010-9718-6 · 2011 · External reference
10.1074/jbc.m109.021485
10.1074/jbc.m109.021485 · External reference
10.1158/0008-5472.can-07-1132
10.1158/0008-5472.can-07-1132 · External reference
10.18632/oncotarget.2970
10.18632/oncotarget.2970 · External reference
SMYD3-mediated H2A.Z.1 methylation promotes cell cycle and cancer proliferation
10.1158/0008-5472.can-16-0500 · 2016 · External reference
10.18632/oncotarget.11898
10.18632/oncotarget.11898 · External reference
10.1002/cam4.1099
10.1002/cam4.1099 · External reference
10.1016/j.isci.2020.101604
10.1016/j.isci.2020.101604 · External reference
10.1104/pp.105.066464
10.1104/pp.105.066464 · External reference
10.1074/jbc.m807168200
10.1074/jbc.m807168200 · External reference
10.1158/1535-7163.mct-12-0006-t
10.1158/1535-7163.mct-12-0006-t · External reference
10.1039/c5ob00886g
10.1039/c5ob00886g · External reference
10.1016/j.bios.2016.08.050
10.1016/j.bios.2016.08.050 · External reference
Discovery of arginine-containing tripeptides as a new class of pancreatic lipase inhibitors
10.4155/fmc-2018-0216 · 2019 · External reference
Fragment screening for a protein-protein interaction inhibitor to WDR5
10.1063/1.5122849 · 2019 · External reference
Hydrophobic interactions at subsite S1’ of human dipeptidyl peptidase IV contribute significantly to the inhibitory effect of tripeptides
10.1016/j.heliyon.2020.e04227 · 2020 · External reference
Elaboration of non-naturally occurring helical tripeptides as p53-MDM2/MDMX interaction inhibitors
10.1248/cpb.c21-00238 · 2021 · External reference
10.1016/j.bpj.2020.12.026
10.1016/j.bpj.2020.12.026 · External reference
10.1098/rsif.2008.0320
10.1098/rsif.2008.0320 · External reference
Codon number shapes peptide redundancy in the universal proteome composition
10.1016/j.peptides.2009.06.035 · 2009 · External reference
10.1016/j.peptides.2010.02.003
10.1016/j.peptides.2010.02.003 · External reference
10.1093/nar/gkaa1100
10.1093/nar/gkaa1100 · External reference
The reactome pathway knowledgebase
2020 · External reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · External reference
10.1128/mcb.25.8.3305-3316.2005
10.1128/mcb.25.8.3305-3316.2005 · External reference
Immune-mediated dormancy: an equilibrium with cancer
10.1189/jlb.1107774 · 2008 · External reference
10.1111/j.1365-2567.2007.02587.x
10.1111/j.1365-2567.2007.02587.x · External reference
10.1152/physrev.00026.2020
10.1152/physrev.00026.2020 · External reference
10.1128/mcb.05437-11
10.1128/mcb.05437-11 · External reference
10.1128/mcb.00319-10
10.1128/mcb.00319-10 · External reference
10.1126/science.1199498
10.1126/science.1199498 · External reference
10.1016/j.ccr.2007.05.008
10.1016/j.ccr.2007.05.008 · External reference
10.3390/ijms21041199
10.3390/ijms21041199 · External reference
10.21873/anticanres.15002
10.21873/anticanres.15002 · External reference
The emerging role of microRNA in regulating the mTOR signaling pathway in immune and inflammatory responses
10.1111/imcb.12477 · 2021 · External reference
10.1038/nri3901
10.1038/nri3901 · External reference
10.4049/jimmunol.2100230
10.4049/jimmunol.2100230 · External reference
10.1371/journal.pone.0065586
10.1371/journal.pone.0065586 · External reference
10.1038/35036093
10.1038/35036093 · External reference
10.1038/nrg1656
10.1038/nrg1656 · External reference
Telomere dysfunction, genome instability and cancer
10.2741/2825 · 2008 · External reference
10.1038/nrc1012
10.1038/nrc1012 · External reference
10.1016/j.ymgme.2021.03.003
10.1016/j.ymgme.2021.03.003 · External reference
10.1158/2159-8290.cd-12-0095
10.1158/2159-8290.cd-12-0095 · External reference
10.1016/j.ccr.2013.12.015
10.1016/j.ccr.2013.12.015 · External reference
10.1038/nrc1098
10.1038/nrc1098 · External reference
10.1158/0008-5472.can-10-1040
10.1158/0008-5472.can-10-1040 · External reference
10.1007/s10911-010-9178-9
10.1007/s10911-010-9178-9 · External reference
10.1073/pnas.1004900107
10.1073/pnas.1004900107 · External reference
10.1038/nrm1261
10.1038/nrm1261 · External reference
10.1038/nrm3012
10.1038/nrm3012 · External reference
10.1016/j.ccell.2018.03.014
10.1016/j.ccell.2018.03.014 · External reference
The landscape of driver mutations in cutaneous squamous cell carcinoma
10.1038/s41525-021-00226-4 · 2021 · External reference
Mouse models in tumor suppression
10.1038/sj.onc.1202573 · 1998 · External reference
10.1038/nrc2399
10.1038/nrc2399 · External reference
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation
10.1093/nar/gkz961 · 2019 · External reference
Role of retinoblastoma protein family (Rb/p105 and Rb2/p130) expression in the histopathological classification of borderline ovarian tumors
10.3389/fmed.2020.596226 · 2020 · External reference
10.4252/wjsc.v12.i6.481
10.4252/wjsc.v12.i6.481 · External reference
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E
10.1101/gad.7.12a.2366 · 1993 · External reference
10.1128/mcb.14.11.7256-7264.1994
10.1128/mcb.14.11.7256-7264.1994 · External reference
10.1126/science.123.3191.309
10.1126/science.123.3191.309 · External reference
10.1126/science.1160809
10.1126/science.1160809 · External reference
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
2014 · External reference
10.1038/nrg3966
10.1038/nrg3966 · External reference
10.1016/j.molcel.2016.02.011
10.1016/j.molcel.2016.02.011 · External reference
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy
10.1038/s41419-018-0336-0 · 2018 · External reference
10.1016/j.molcel.2008.03.003
10.1016/j.molcel.2008.03.003 · External reference
10.1186/1741-7007-11-36
10.1186/1741-7007-11-36 · External reference
10.1002/cbin.10915
10.1002/cbin.10915 · External reference
Structure and physiological regulation of AMPK
2018 · External reference
Interactive roles for AMPK and glycogen from cellular energy sensing to exercise metabolism
10.3390/ijms19113344 · 2018 · External reference
10.1016/j.cell.2018.03.022
10.1016/j.cell.2018.03.022 · External reference
Genomic correlates of immune-cell infiltrates in colorectal carcinoma
10.1016/j.celrep.2016.10.009 · 2016 · External reference
10.1016/j.cels.2018.03.002
10.1016/j.cels.2018.03.002 · External reference
10.1016/j.ccell.2018.03.007
10.1016/j.ccell.2018.03.007 · External reference
10.1016/j.cell.2018.02.052
10.1016/j.cell.2018.02.052 · External reference
10.1016/j.cell.2018.03.035
10.1016/j.cell.2018.03.035 · External reference
10.1038/ng.2591
10.1038/ng.2591 · External reference
10.1038/onc.2011.84
10.1038/onc.2011.84 · External reference
Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer
10.3892/etm.2017.4692 · 2017 · External reference
Structural and functional profiling of the human histone methyltransferase SMYD3
10.1371/journal.pone.0022290 · 2011 · External reference
Hallmarks of cancer-the new testament
10.1098/rsob.200358 · 2021 · External reference
10.1038/s41580-018-0068-0
10.1038/s41580-018-0068-0 · External reference
10.3390/cancers13174427
10.3390/cancers13174427 · External reference
10.1093/nar/gky1131
10.1093/nar/gky1131 · External reference
10.1016/s0092-8674(03)00929-2
10.1016/s0092-8674(03)00929-2 · External reference
The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention
10.4161/cc.3.1.607 · 2004 · External reference
10.1007/s00249-014-0981-x
10.1007/s00249-014-0981-x · External reference
The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage
10.1158/0008-5472.can-10-0475 · 2010 · External reference
Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block
10.1093/emboj/20.3.422 · 2001 · External reference
10.1038/ncb1235
10.1038/ncb1235 · External reference
10.1158/2159-8290.cd-20-0187
10.1158/2159-8290.cd-20-0187 · External reference
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
10.3324/haematol.2021.278853 · 2021 · External reference
Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trial
10.1200/jco.19.00368 · 2020 · External reference
10.1111/cas.14582
10.1111/cas.14582 · External reference
Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer
10.1002/ctm2.33 · 2020 · External reference
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children’s Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)
10.1002/pbc.29065 · 2021 · External reference
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
10.1007/s00280-020-04176-z · 2020 · External reference
Mapping the protein interaction landscape for fully functionalized small-molecule probes in human cells
10.1021/ja505517t · 2014 · External reference
Fully functionalized small-molecule probes for integrated phenotypic screening and target identification
10.1021/ja304213w · 2012 · External reference
10.1021/ar700030k
10.1021/ar700030k · External reference
10.1093/bioinformatics/btx752
10.1093/bioinformatics/btx752 · External reference
